14 Federal Register documents in this docket
| Doc # | Type | Title | Published | Agency |
|---|---|---|---|---|
| 2025-22249 | Notice | Product-Specific Guidance on Estradiol; Draft Guidance for Industry; Availabilit... | Dec 8, 2025 | Food and Drug Administration |
| 2025-22131 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | Dec 5, 2025 | Food and Drug Administration |
| 2025-20548 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | Nov 21, 2025 | Food and Drug Administration |
| 2025-19345 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | Oct 2, 2025 | Food and Drug Administration |
| 2025-15082 | Notice | Product-Specific Guidance on Iron Sucrose; Draft Guidance for Industry; Availabi... | Aug 8, 2025 | Food and Drug Administration |
| 2025-09069 | Notice | Product-Specific Guidance on Roflumilast; Draft Guidance for Industry; Availabil... | May 21, 2025 | Food and Drug Administration |
| 2025-09067 | Notice | Product-Specific Guidance on Fluticasone Propionate; Draft Guidance for Industry... | May 21, 2025 | Food and Drug Administration |
| 2025-09068 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | May 21, 2025 | Food and Drug Administration |
| 2024-27048 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | Nov 20, 2024 | Food and Drug Administration |
| 2024-25391 | Notice | Product-Specific Guidances; Revised Draft Guidances for Industry; Availability | Oct 31, 2024 | Food and Drug Administration |
| 2024-18997 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | Aug 23, 2024 | Food and Drug Administration |
| 2024-10896 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | May 17, 2024 | Food and Drug Administration |
| 2024-06985 | Notice | Product-Specific Guidance for Oxymetazoline Hydrochloride; Draft Guidance for In... | Apr 3, 2024 | Food and Drug Administration |
| 2024-03300 | Notice | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Avai... | Feb 16, 2024 | Food and Drug Administration |